EU Gives Initial Okay to Canakinumab for Gouty Arthritis

Published January 24, 2013

EU Gives Initial Okay to Canakinumab for Gouty Arthritis

Filed under: drug rehab treatment programs

In a news release from the company, Novartis says the drug is already approved for treatment of cryopyrin-associated periodic syndromes in more than 60 countries, including the United States, European Union (EU), Switzerland, and Japan. Gouty arthritis …
Read more on Medscape

Legalizing pot dangerous, group says

Filed under: drug rehab treatment programs

At the same time, the group is developing model legislation to take to lawmakers to achieve such goals as improving access to drug-treatment programs, he said. Leaders of Project SAM have highlighted studies that show a link between marijuana and …
Read more on Columbus Dispatch

Newly approved oral drug is effective in patients with rheumatoid arthritis

Filed under: drug rehab treatment programs

The U.S. Food and Drug Administration (FDA) approved a new drug for treating moderate to severe rheumatoid arthritis. The new drug, tofacitinib, which is an oral JAK inhibitor, has been tested in several clinical trials and has been shown to slow the …
Read more on Doctor Tipster